Fund raising plans lift Glenmark shares by over 4%

Last Updated: Monday, April 20, 2015, 21:54

Shares of Glenmark Pharmaceuticals went up by over 4 percent Monday as it plans to raise up to Rs 945 crore by issuing over one crore shares to Temasek Holdings, the investment arm of Singapore government, on a preferential basis.

Glenmark to raise Rs 945 crore from Temasek Holdings

Last Updated: Friday, April 17, 2015, 20:08

Glenmark Pharmaceuticals plans to raise up to Rs 945 crore by issuing over one crore shares to Temasek Holdings, the investment arm of the Singapore government, on a preferential basis.

Glenmark to pay $24.96 mn to US to settle pricing probe

Last Updated: Wednesday, April 8, 2015, 17:50

In a regulatory filing with the National Stock Exchange, the company said that under the terms of the agreed settlement, "there is no admission of liability".

Glenmark's subsidiary to pay $25 mn to settle a pricing case

Last Updated: Wednesday, April 8, 2015, 13:14

Pharmaceutical major Glenmark on Wednesday said its US subsidiary will pay USD 25 million to the federal government there as well as to the Texas state administration to settle a pricing investigation.

CCEA clears Glenmark, Aurobindo proposals worth Rs 4,187 cr

Last Updated: Tuesday, April 7, 2015, 21:49

Pharmaceutical majors Glenmark and Aurobindo's foreign investment proposals, worth Rs 4,187 crore, were approved by the government Tuesday.

Glenmark gets USFDA nod for post-menopause osteoporosis drug

Last Updated: Tuesday, April 7, 2015, 12:11

The approval for sale of Norethindrone Acetate and Ethinyl Estradiol tablets was given to Glenmark Generics Inc USA, a subsidiary of Glenmark Generics Ltd.

SC stays Delhi HC order till April 28 against Glenmark

Last Updated: Wednesday, March 25, 2015, 19:55

Supreme Court today stayedtill April 28 the order of Delhi High Court barring Indian pharma major Glenmark Pharamceuticals from making, marketing or selling its anti-diabetes medicines in which US drug major Merck Sharp and Dohme (MSD) has claimed patent right.

High Court bars Glenmark from making anti-diabetes drugs

Last Updated: Friday, March 20, 2015, 17:34

The Delhi High Court on Friday restrained Indian firm Glenmark Pharmaceuticals from manufacturing, marketing or selling its anti-diabetes drugs Zita and Zita-Met, saying it has "prima facie" infringed the patent of US drug major Merck Sharp and Dohme (MSD).

Glenmark gets nod from Russia for Salmecort MDI inhaler

Last Updated: Thursday, March 12, 2015, 17:14

Glenmark Pharmaceuticals has received approval for generic Salmecort MDI inhaler used for management of asthma and pulmonary disease from Russia's Ministry of Health.

'Dr Reddy's in talks to buy UCB India business for $135 million'

Last Updated: Tuesday, March 10, 2015, 19:34

Drugmaker Dr Reddy`s Laboratories Ltd is in talks to acquire the Indian operations of Belgian pharmaceutical company UCB SA for about $135 million, said a person with direct knowledge of the matter.

Glenmark gets USFDA nod to sell generic blood pressure drug

Last Updated: Thursday, February 26, 2015, 12:18

Glenmark Pharmaceuticals today announced receipt of approval from the US health regulator to sell its generic version of AbbVie Inc's blood pressure drug Tarka in the American market.

FIPB refers Rs 4,197 cr Glenmark, Aurobindo proposals to CCEA

Last Updated: Thursday, February 19, 2015, 21:15

The Finance Ministry Thursday referred the foreign investment proposals worth Rs 4,187 crore in pharma firms - Glenmark and Aurobindo - to the Cabinet Committee on Economic Affairs.